KR100850545B1 - 신규한 개 인플루엔자 바이러스 및 이의 백신 - Google Patents

신규한 개 인플루엔자 바이러스 및 이의 백신 Download PDF

Info

Publication number
KR100850545B1
KR100850545B1 KR1020070109535A KR20070109535A KR100850545B1 KR 100850545 B1 KR100850545 B1 KR 100850545B1 KR 1020070109535 A KR1020070109535 A KR 1020070109535A KR 20070109535 A KR20070109535 A KR 20070109535A KR 100850545 B1 KR100850545 B1 KR 100850545B1
Authority
KR
South Korea
Prior art keywords
influenza virus
seq
virus
vaccine
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020070109535A
Other languages
English (en)
Korean (ko)
Inventor
조영식
하건우
오진식
강동석
송대섭
강보규
이철승
Original Assignee
주식회사 에니멀제네틱스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to KR1020070109535A priority Critical patent/KR100850545B1/ko
Application filed by 주식회사 에니멀제네틱스 filed Critical 주식회사 에니멀제네틱스
Priority to AT07834095T priority patent/ATE554789T1/de
Priority to EP07834095A priority patent/EP2078083B1/en
Priority to US12/375,924 priority patent/US8246962B2/en
Priority to CN2007800299717A priority patent/CN101605898B/zh
Priority to JP2010530910A priority patent/JP5404636B2/ja
Priority to PCT/KR2007/005789 priority patent/WO2009057843A1/en
Priority to ES07834095T priority patent/ES2383158T3/es
Application granted granted Critical
Publication of KR100850545B1 publication Critical patent/KR100850545B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020070109535A 2007-10-30 2007-10-30 신규한 개 인플루엔자 바이러스 및 이의 백신 Active KR100850545B1 (ko)

Priority Applications (8)

Application Number Priority Date Filing Date Title
KR1020070109535A KR100850545B1 (ko) 2007-10-30 2007-10-30 신규한 개 인플루엔자 바이러스 및 이의 백신
EP07834095A EP2078083B1 (en) 2007-10-30 2007-11-16 A novel canine influenza virus and vaccine therefore
US12/375,924 US8246962B2 (en) 2007-10-30 2007-11-16 Canine influenza virus and vaccine therefore
CN2007800299717A CN101605898B (zh) 2007-10-30 2007-11-16 新型犬流感病毒及用于它的疫苗
AT07834095T ATE554789T1 (de) 2007-10-30 2007-11-16 Neues hundeinfluenza-virus und imfpstoff hierfür
JP2010530910A JP5404636B2 (ja) 2007-10-30 2007-11-16 新規のイヌインフルエンザウイルス及びこのワクチン
PCT/KR2007/005789 WO2009057843A1 (en) 2007-10-30 2007-11-16 A novel canine influenza virus and vaccine therefore
ES07834095T ES2383158T3 (es) 2007-10-30 2007-11-16 Un nuevo virus de influencia canina y la vacuna correspondiente

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070109535A KR100850545B1 (ko) 2007-10-30 2007-10-30 신규한 개 인플루엔자 바이러스 및 이의 백신

Publications (1)

Publication Number Publication Date
KR100850545B1 true KR100850545B1 (ko) 2008-08-05

Family

ID=39881230

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070109535A Active KR100850545B1 (ko) 2007-10-30 2007-10-30 신규한 개 인플루엔자 바이러스 및 이의 백신

Country Status (8)

Country Link
US (1) US8246962B2 (enExample)
EP (1) EP2078083B1 (enExample)
JP (1) JP5404636B2 (enExample)
KR (1) KR100850545B1 (enExample)
CN (1) CN101605898B (enExample)
AT (1) ATE554789T1 (enExample)
ES (1) ES2383158T3 (enExample)
WO (1) WO2009057843A1 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101390554B1 (ko) 2012-05-22 2014-05-21 충남대학교산학협력단 신규한 개 인플루엔자 바이러스(ｈ３ｎ２), 이를 포함하는 백신 조성물 및 ｈ３ｎ２ 바이러스 검정 키트
KR101484588B1 (ko) * 2012-10-24 2015-01-20 대한민국 개 인플루엔자 ｖｌｐ 백신의 제조방법
KR20150027882A (ko) 2013-08-29 2015-03-13 한국생명공학연구원 이종 인플루엔자 바이러스에 대한 백신 조성물
KR101511619B1 (ko) * 2013-04-30 2015-04-13 한국생명공학연구원 개 인플루엔자 바이러스 h3n2의 ha1 단백질을 항원으로 포함하는 개 인플루엔자 바이러스 h3n2에 특이적인 혈청 진단용 키트
WO2016186259A1 (ko) * 2015-05-18 2016-11-24 한국생명공학연구원 범용성 개 인플루엔자 바이러스 백신 조성물

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101838708B (zh) * 2010-03-30 2012-07-18 华南农业大学 一种检测犬流感的方法
MX350718B (es) 2011-03-14 2017-09-14 Boehringer Ingelheim Vetmedica Inc Vacuna de rinitis equina.
CN102220293B (zh) * 2011-05-26 2012-12-19 中国农业科学院上海兽医研究所 犬流感重组病毒及其制备方法和应用
CN103223162B (zh) * 2013-04-03 2014-07-30 华南农业大学 一株h3n2犬流感病毒株cgd1的应用
EP3313440A2 (en) 2015-06-26 2018-05-02 Merial, Inc. Inactivated canine influenza vaccines and methods of making and uses thereof
WO2017031401A2 (en) * 2015-08-20 2017-02-23 University Of Rochester Ns1 truncated virus for the development of canine influenza vaccines
WO2017031404A1 (en) 2015-08-20 2017-02-23 University Of Rochester Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus
CN105463021A (zh) * 2015-12-25 2016-04-06 华南农业大学 表达h3n2犬流感ha蛋白的重组犬腺病毒疫苗载体的构建方法
CN106248937A (zh) * 2016-09-09 2016-12-21 华中农业大学 一种检测犬副流感病毒抗体的间接elisa试剂盒
CA3087239A1 (en) 2018-02-27 2019-09-06 University Of Rochester Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (eiv) in horses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0733113B1 (en) * 1994-01-11 2007-05-02 Vlaams Interuniversitair Instituut voor Biotechnologie Influenza vaccine
AT407958B (de) * 1999-02-11 2001-07-25 Immuno Ag Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
KR20110126726A (ko) * 2005-10-07 2011-11-23 화이자 프로덕츠 인코포레이티드 개과 동물의 인플루엔자의 치료를 위한 백신 및 방법

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
NCBI GenBank AY862607 (2005. 02. 07.)*
NCBI GenBank AY862641 (2005. 02. 07.)*
The Journal of Infectious Disease, vol.194, pages 11-118.(2006. 11.)*

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101390554B1 (ko) 2012-05-22 2014-05-21 충남대학교산학협력단 신규한 개 인플루엔자 바이러스(ｈ３ｎ２), 이를 포함하는 백신 조성물 및 ｈ３ｎ２ 바이러스 검정 키트
KR101484588B1 (ko) * 2012-10-24 2015-01-20 대한민국 개 인플루엔자 ｖｌｐ 백신의 제조방법
KR101511619B1 (ko) * 2013-04-30 2015-04-13 한국생명공학연구원 개 인플루엔자 바이러스 h3n2의 ha1 단백질을 항원으로 포함하는 개 인플루엔자 바이러스 h3n2에 특이적인 혈청 진단용 키트
KR20150027882A (ko) 2013-08-29 2015-03-13 한국생명공학연구원 이종 인플루엔자 바이러스에 대한 백신 조성물
WO2016186259A1 (ko) * 2015-05-18 2016-11-24 한국생명공학연구원 범용성 개 인플루엔자 바이러스 백신 조성물

Also Published As

Publication number Publication date
EP2078083B1 (en) 2012-04-25
ES2383158T3 (es) 2012-06-18
CN101605898B (zh) 2012-05-23
WO2009057843A1 (en) 2009-05-07
JP2011501950A (ja) 2011-01-20
US20100285063A1 (en) 2010-11-11
CN101605898A (zh) 2009-12-16
US8246962B2 (en) 2012-08-21
ATE554789T1 (de) 2012-05-15
EP2078083A4 (en) 2009-10-28
EP2078083A1 (en) 2009-07-15
JP5404636B2 (ja) 2014-02-05

Similar Documents

Publication Publication Date Title
KR100850545B1 (ko) 신규한 개 인플루엔자 바이러스 및 이의 백신
US20190314488A1 (en) Materials and methods for respiratory disease control in canines
RU2711807C2 (ru) Вирус гриппа, способный инфицировать собачьих, и его применение
JP6301855B2 (ja) イヌにおける呼吸器疾患管理のための材料および方法
AU2020264347B2 (en) Influenza viruses able to infect canids, uses thereof
KR101390554B1 (ko) 신규한 개 인플루엔자 바이러스(ｈ３ｎ２), 이를 포함하는 백신 조성물 및 ｈ３ｎ２ 바이러스 검정 키트
KR101626798B1 (ko) 신규한 h3n2 혈청형의 인플루엔자 바이러스 및 이를 포함하는 백신 조성물
KR101627623B1 (ko) 이종 인플루엔자 바이러스에 대한 백신 조성물
US11865172B2 (en) Materials and methods for respiratory disease control in canines
KR20250042901A (ko) 유전자가 재배열된 h3n1 혈청형의 개 인플루엔자 바이러스 및 이를 포함하는 백신 조성물
AU2012238228B2 (en) Materials and methods for respiratory disease control in canines
HK1167660B (en) Materials for respiratory disease control in canines

Legal Events

Date Code Title Description
A201 Request for examination
A302 Request for accelerated examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20071030

PA0201 Request for examination
PA0302 Request for accelerated examination

Patent event date: 20071030

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20080116

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20080513

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20080717

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20080730

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20080731

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20110729

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20120730

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20130724

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20130724

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20140716

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20140716

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20150819

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20150819

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20160728

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20160728

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20170601

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20170601

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20180529

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20180529

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20190529

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20190529

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20200701

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20210714

Start annual number: 14

End annual number: 14

PR1001 Payment of annual fee

Payment date: 20220616

Start annual number: 15

End annual number: 15

PR1001 Payment of annual fee

Payment date: 20230712

Start annual number: 16

End annual number: 16

PR1001 Payment of annual fee

Payment date: 20240703

Start annual number: 17

End annual number: 17

PR1001 Payment of annual fee

Payment date: 20250625

Start annual number: 18

End annual number: 18